SOLIGENIX, INC. Amortization of Debt Discount (Premium)
SOLIGENIX, INC. (SNGX) reported Amortization of Debt Discount (Premium) of $7.28 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2018-03-15
- SOLIGENIX, INC. amortization of debt discount (premium) for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- SOLIGENIX, INC. amortization of debt discount (premium) for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- SOLIGENIX, INC. amortization of debt discount (premium) for the quarter ending 2016-06-30 was $1.03K.
- SOLIGENIX, INC. amortization of debt discount (premium) for the quarter ending 2016-03-31 was $6.25K.
- SOLIGENIX, INC. amortization of debt discount (premium) for fiscal 2016 was $7.28K, a 31.62% decline from fiscal 2015.
- SOLIGENIX, INC. amortization of debt discount (premium) for fiscal 2015 was $10.65K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | $1.03K derived: sum of 3 quarters · filed 2018-03-15 | $7.28K 10-K · filed 2018-03-15 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $1.03K derived: sum of 2 quarters · filed 2017-11-06 | $7.28K 10-Q · filed 2017-11-06 | $13.60K derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-06-30 | $1.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $7.28K 10-Q · filed 2017-08-11 | $13.60K derived: sum of 3 quarters · filed 2017-08-11 | $17.93K derived: sum of 4 quarters · filed 2017-08-11 |
| 2016-03-31 | $6.25K 10-Q · filed 2017-05-11 | $12.57K derived: sum of 2 quarters · filed 2017-05-11 | $16.90K derived: sum of 3 quarters · filed 2017-05-11 | |
| 2015-12-31 | $6.32K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | $10.65K derived: sum of 2 quarters · filed 2017-03-27 | $10.65K 10-K · filed 2017-03-27 | |
| 2015-09-30 | $4.33K 10-Q · filed 2015-11-12 | $4.33K 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |